These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 24025063)
1. Zolpidem arousing effect in persistent vegetative state patients: autonomic, EEG and behavioral assessment. Machado C; Estévez M; Rodríguez R; Pérez-Nellar J; Chinchilla M; DeFina P; Leisman G; Carrick FR; Melillo R; Schiavi A; Gutiérrez J; Carballo M; Machado A; Olivares A; Pérez-Cruz N Curr Pharm Des; 2014; 20(26):4185-202. PubMed ID: 24025063 [TBL] [Abstract][Full Text] [Related]
2. Zolpidem efficacy and safety in disorders of consciousness. Machado C; Estévez M; Rodriguez-Rojas R Brain Inj; 2018; 32(4):530-531. PubMed ID: 29393689 [TBL] [Abstract][Full Text] [Related]
3. Autonomic, EEG, and behavioral arousal signs in a PVS case after Zolpidem intake. Machado C; Estévez M; Pérez-Nellar J; Gutiérrez J; Rodríguez R; Carballo M; Chinchilla M; Machado A; Portela L; García-Roca MC; Beltrán C Can J Neurol Sci; 2011 Mar; 38(2):341-4. PubMed ID: 21320843 [No Abstract] [Full Text] [Related]
4. Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS. Rodriguez-Rojas R; Machado C; Alvarez L; Carballo M; Estevez M; Perez-Nellar J; Pavon N; Chinchilla M; Carrick FR; DeFina P Brain Inj; 2013; 27(11):1320-9. PubMed ID: 23924270 [TBL] [Abstract][Full Text] [Related]
5. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Whyte J; Myers R Am J Phys Med Rehabil; 2009 May; 88(5):410-8. PubMed ID: 19620954 [TBL] [Abstract][Full Text] [Related]
6. Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics. Snyman N; Egan JR; London K; Howman-Giles R; Gill D; Gillis J; Scheinberg A Neuropediatrics; 2010 Oct; 41(5):223-7. PubMed ID: 21210338 [TBL] [Abstract][Full Text] [Related]
7. A Cuban perspective on management of persistent vegetative state. Machado C; Estévez M; Rodríguez R; Pérez-Nellar J; Gutiérrez J; Carballo M; Olivares A; Fleitas M; Pando A; Beltrán C MEDICC Rev; 2012 Jan; 14(1):44-8. PubMed ID: 22334112 [TBL] [Abstract][Full Text] [Related]
8. Zolpidem arouses patients in vegetative state after brain injury: quantitative evaluation and indications. Du B; Shan A; Zhang Y; Zhong X; Chen D; Cai K Am J Med Sci; 2014 Mar; 347(3):178-82. PubMed ID: 23462249 [TBL] [Abstract][Full Text] [Related]
9. Zolpidem in a minimally conscious state. Singh R; McDonald C; Dawson K; Lewis S; Pringle AM; Smith S; Pentland B Brain Inj; 2008 Jan; 22(1):103-6. PubMed ID: 18183514 [TBL] [Abstract][Full Text] [Related]
10. EEG findings in the persistent vegetative state. Kulkarni VP; Lin K; Benbadis SR J Clin Neurophysiol; 2007 Dec; 24(6):433-7. PubMed ID: 18090523 [TBL] [Abstract][Full Text] [Related]
11. The Autonomic System Functional State Predicts Responsiveness in Disorder of Consciousness. Riganello F; Cortese MD; Dolce G; Lucca LF; Sannita WG J Neurotrauma; 2015 Jul; 32(14):1071-7. PubMed ID: 25604680 [TBL] [Abstract][Full Text] [Related]
12. Drug induced arousal from the permanent vegetative state. Clauss R; Nel W NeuroRehabilitation; 2006; 21(1):23-8. PubMed ID: 16720934 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects. Struyk A; Gargano C; Drexel M; Stoch SA; Svetnik V; Ma J; Mayleben D Eur Neuropsychopharmacol; 2016 Oct; 26(10):1649-56. PubMed ID: 27554636 [TBL] [Abstract][Full Text] [Related]
14. Transient awakening from vegetative state: is high-dose zolpidem more effective? Calabrò RS; Aricò I; De Salvo S; Conti-Nibali V; Bramanti P Psychiatry Clin Neurosci; 2015 Feb; 69(2):122-3. PubMed ID: 24965312 [No Abstract] [Full Text] [Related]
15. The influence of acoustic and tactile stimulation on vegetative parameters and EEG in persistent vegetative state. Keller I; Hülsdunk A; Müller F Funct Neurol; 2007; 22(3):159-63. PubMed ID: 17925166 [TBL] [Abstract][Full Text] [Related]
16. Conjugate eye movements and gamma power modulation of the EEG in persistent vegetative state. Balazs S; Stepan C; Binder H; von Gizycki H; Avitable M; Obersteiner A; Rattay F; Selesnick I; Bodis-Wollner I J Neurol Sci; 2006 Jul; 246(1-2):65-9. PubMed ID: 16580696 [TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428 [TBL] [Abstract][Full Text] [Related]
18. A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials. Sutton JA; Clauss RP Brain Inj; 2017; 31(8):1019-1027. PubMed ID: 28534652 [TBL] [Abstract][Full Text] [Related]
19. EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. Lundahl J; Deacon S; Maurice D; Staner L J Psychopharmacol; 2012 Aug; 26(8):1081-7. PubMed ID: 22057018 [TBL] [Abstract][Full Text] [Related]
20. Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: a case report. Shames JL; Ring H Arch Phys Med Rehabil; 2008 Feb; 89(2):386-8. PubMed ID: 18226667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]